← All organizations

Swiss Paraplegic Research

Academic/Hospital

Also known as: Swiss Paraplegic Research

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Oct 31, 2019

Timeline

No events for the selected filters.

Drugs by trial phase (2 distinct, 2 trials)

Phase 4 (1 own, 0 via acquisition)

killed enterotoxigenic escherichia coli vaccine

Phase 2 (1 own, 0 via acquisition)

metopimazine

Indications

Studied for

Recent trials (2)

NCT04049994CollaboratorPhase 4Oct 31, 2019
NCT03935321CollaboratorPhase 2May 15, 2019

Details

Last known activity: Oct 31, 2019